GR1006535B - Προστασια ιατρικο-φαρμακευτικων σκευασματων και νεα μεθοδολογια χορηγησης τους - Google Patents

Προστασια ιατρικο-φαρμακευτικων σκευασματων και νεα μεθοδολογια χορηγησης τους

Info

Publication number
GR1006535B
GR1006535B GR20080100446A GR20080100446A GR1006535B GR 1006535 B GR1006535 B GR 1006535B GR 20080100446 A GR20080100446 A GR 20080100446A GR 20080100446 A GR20080100446 A GR 20080100446A GR 1006535 B GR1006535 B GR 1006535B
Authority
GR
Greece
Prior art keywords
medical
administration
protection
methodoly
fot
Prior art date
Application number
GR20080100446A
Other languages
English (en)
Inventor
-
Original Assignee
�������� ��������-��������
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������� ��������-�������� filed Critical �������� ��������-��������
Priority to GR20080100446A priority Critical patent/GR1006535B/el
Priority to US12/327,947 priority patent/US20100004212A1/en
Publication of GR1006535B publication Critical patent/GR1006535B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση λύνει κατά τον καλύτερο τρόπο τρία προβλήματα που απασχολούν την παραγωγή, διάθεση, και χρήση φαρμακευτικών, ιατρικών και άλλων σκευασμάτων: Α) την προστασία τους από οξειδωτικές αλλοιώσεις με χρήση αναγωγικών ή αντιοξειδωτικών ουσιών - μιγμάτων. Β) Την προστασία από αλλοιώσεις που οφείλονται σε έκθεση στο φως κυρίως για φωτοευαίσθητα μείγματα - ουσίες, και Γ) Μέσω μιας μεθοδολογίας ειδικής (κοίλα πώματα) το τελικό προϊόν αποκτά τις ανωτέρω Α και Β προστασίες ενώ ταυτόχρονα απλοποιείται η παραγωγή και η ασφάλεια των παραγομένων ως άνω φαρμακευτικών και ιατρικών προϊόντων κατά τον καλύτερο, οικονομικότερο, αποδοτικότερο τρόπο και απλοποιείται πολύ η χορήγηση τους ακόμα και σε πιο ακραίες συνθήκες, περιοχές και χρήσεις.
GR20080100446A 2008-07-01 2008-07-01 Προστασια ιατρικο-φαρμακευτικων σκευασματων και νεα μεθοδολογια χορηγησης τους GR1006535B (el)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GR20080100446A GR1006535B (el) 2008-07-01 2008-07-01 Προστασια ιατρικο-φαρμακευτικων σκευασματων και νεα μεθοδολογια χορηγησης τους
US12/327,947 US20100004212A1 (en) 2008-07-01 2008-12-04 Dual protection of medicinal- pharmaceutical products and new techniques for their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20080100446A GR1006535B (el) 2008-07-01 2008-07-01 Προστασια ιατρικο-φαρμακευτικων σκευασματων και νεα μεθοδολογια χορηγησης τους

Publications (1)

Publication Number Publication Date
GR1006535B true GR1006535B (el) 2009-09-21

Family

ID=41254574

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20080100446A GR1006535B (el) 2008-07-01 2008-07-01 Προστασια ιατρικο-φαρμακευτικων σκευασματων και νεα μεθοδολογια χορηγησης τους

Country Status (2)

Country Link
US (1) US20100004212A1 (el)
GR (1) GR1006535B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210056496A1 (en) * 2019-08-21 2021-02-25 David Edward Gajeski System for facilitating purchase of prescription drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103445A (ja) * 1984-10-24 1986-05-21 三菱瓦斯化学株式会社 脱酸素剤包装容器
US5958479A (en) * 1996-04-19 1999-09-28 American Roland Chemical Corporation Antioxidant/desiccant packet and method for use thereof
GR1003080B (el) * 1997-11-21 1999-02-25 Συντηρηση ενζυμων σε κοιλο πωμα φιαλιδιων για χρηση τους σε καλλυντικα σκευασματα

Also Published As

Publication number Publication date
US20100004212A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
UY31747A (es) Nuevas formulaciones, comprimidos que comprenden tales formulaciones, su uso y procedimiento para su preparacion
CL2013000713A1 (es) Compuestos pirazin-2-cabonil-imino-1,3,8-triaza-espiro-[4.5]-decan-sustituidos, bloqueadores del canal de sodio epitelial (enac); composicion farmaceutica que los incluye; metodo de prevencion o tratamiento; y su uso para tratar una enfermedad o condicion mediada por el bloqueo del canal de sodio epitelial.
DOP2011000218A (es) Derivados de sulfonamida
AR086409A1 (es) Formulaciones de gel bioadhesivo de testosterona intranasal y uso del mismo para tratar hipogonadismo masculino
IN2014DN06501A (el)
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
ECSP12011834A (es) Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, métodos para su tratamiento y sus usos.
UY31350A1 (es) (carboxilalquilenfenil)feniloxamidas, procedimiento para su preparación y su utilización como medicamentos
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
UY33277A (es) Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso
CU20110153A7 (es) Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BR112015007814A2 (pt) diagnóstico, prevenção e tratamento de doenças da articulação
CU20140037A7 (es) Derivados de estra- 1,3,5(10), 16- tetraen- 3- carboximida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
BR112014007902A2 (pt) composições farmacêuticas compreendendo 40-o-(2-hidróxi)etil-rapamicina
PE20150353A1 (es) Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos
UY30986A1 (es) Derivados fluorinados de deferiprona
UY31922A (es) Compuestos
DOP2014000124A (es) Derivados de 6,7-dihidro-5h-benzo[7]anuleno, procesos para su preparación, productos farmacéuticos que comprenden a los mismos y su uso en la preparación de medicamentos
MX2012007166A (es) Composicion antiviral sinergica y su uso.
GT201400288A (es) "compuestos de fenoxietil piperidina"
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20130104